Skip to main content
SpringerLink
Log in

Relation Between C-Reactive Protein and Impaired Fasting Glucose in Obese Subjects

  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

Chronic systemic inflammation, characterized by elevated levels of the acute phase proteins, such as C-reactive protein (CRP), plays an important role in the pathogenesis of glucose metabolic disturbances and diabetes. The aim of this study was to determine if the elevated levels of CRP are associated with impaired fasting glucose (IFG) in obese subjects. Healthy obese men and nonpregnant obese women were enrolled in a case-control study. Individuals with new diagnosis of IFG were considered as cases and compared with a control group without IFG. Elevated CRP was defined by high-sensitivity C-reactive protein (hsCRP) levels between 3.0 and 10.0 mg/L and new diagnosis of IFG by the presence of fasting plasma glucose levels of 100 to 126 mg/dL. A total of 74 subjects were allocated into the case group and compared with 74 subjects in the control group. Elevated hsCRP was identified in 61 (41.2 %) and 34 (23.0 %) individuals in the case and control groups, respectively (p < 0.001). The adjusted odds ratio used to assess the association between elevated hsCRP levels and IFG was 3.36; 95 % confidence interval was 1.66–6.79. In conclusion, the elevated hsCRP levels are associated with IFG in obese subjects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ford, E.S. 2005. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care 28(11): 2745–2749.

    Article  PubMed  Google Scholar 

  2. Hajer, G.R., T.W. van Haeften, and F.L. Visseren. 2008. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. European Heart Journal 29(24): 2959–2971.

    Article  PubMed  CAS  Google Scholar 

  3. Hansen, D., P. Dendale, M. Beelen, R.A. Jonkers, A. Mullens, L. Corluy, et al. 2010. Plasma adipokine and inflammatory marker concentrations are altered in obese, as opposed to non-obese, type 2 diabetes patients. European Journal of Applied Physiology 109(3): 397–404.

    Article  PubMed  CAS  Google Scholar 

  4. Browning, L.M., J.D. Krebs, E.C. Magee, G. Frühbeck, and S.A. Jebb. 2008. Circulating markers of inflammation and their link to indices of adiposity. Obesity Facts 1(5): 259–265.

    Article  PubMed  CAS  Google Scholar 

  5. Pickup, J.C., and M.A. Crook. 1998. Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 41(10): 1241–1248.

    Article  PubMed  CAS  Google Scholar 

  6. Pickup, J.C. 2004. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 27(3): 813–823.

    Article  PubMed  Google Scholar 

  7. Pearson, T., G. Mensah, W. Alexander, J.L. Anderson, R.O. Cannon 3rd, M. Criqui, et al. 2003. Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107(3): 499–551.

    Article  PubMed  Google Scholar 

  8. Lagrand, W.K., C.A. Visser, W.T. Hermens, H.W. Niessen, F.W. Verheugt, G.J. Wolbink, et al. 1999. C-reactive protein as a cardiovascular risk factor: More than an epiphenomenon? Circulation 100(1): 96–102.

    Article  PubMed  CAS  Google Scholar 

  9. Yudkin, J.S., C.D.A. Stehouwer, J.J. Emeis, and S.W. Coppack. 1999. C-reactive protein in healthy subjects: Association with obesity, insulin resistance, and endothelial dysfunction: A potential role for cytokines originating from the adipose tissue? Arteriosclerosis, Thrombosis, and Vascular Biology 19(4): 972–978.

    Article  PubMed  CAS  Google Scholar 

  10. Festa, A., R. D’Agostino, G. Howard, L. Mykkänen, R.P. Tracey, and S.M. Haffner. 2000. Chronic subclinical inflammation as part of the insulin resistance syndrome: The Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102(1): 42–47.

    Article  PubMed  CAS  Google Scholar 

  11. Sakkinen, P.A., P. Wahl, M. Cushman, M.R. Lewis, and R.P. Tracey. 2000. Clustering of procoagulation, inflammation and fibrinolysis variables with metabolic factors in insulin resistance syndrome. American Journal of Epidemiology 152(10): 897–907.

    Article  PubMed  CAS  Google Scholar 

  12. Hak, E.A., H.A. Pols, C.D.A. Stehouwer, J. Meijer, A.J. Kiliaan, A. Hofman, et al. 2001. Markers of inflammation and cellular adhesion molecules in relation to insulin resistance in nondiabetic elderly: The Rotterdam Study. Journal of Clinical Endocrinology and Metabolism 86(9): 4398–4405.

    Article  PubMed  CAS  Google Scholar 

  13. Temelkova-Kurktschiev, T., G. Siegert, S. Bergmann, E. Henkel, C. Koehler, W. Jaross, et al. 2002. Subclinical inflammation is strongly related to insulin resistance but not insulin secretion in a high risk population for diabetes. Metabolism 51(6): 743–749.

    Article  PubMed  CAS  Google Scholar 

  14. Müller, S., S. Martin, W. Koenig, P. Hanifi-Moghaddam, W. Rathmann, B. Haastert, et al. 2002. Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-alpha or its receptors. Diabetologia 45(6): 805–812.

    Article  PubMed  Google Scholar 

  15. Temelkova-Kurktschiev, T., E. Henkel, C. Koehler, K. Karrei, and M. Hanefield. 2002. Subclinical inflammation in newly detected type II diabetes and impaired glucose tolerance. Diabetologia 45(1): 151.

    Article  PubMed  CAS  Google Scholar 

  16. Nichols, G.A., T.A. Hillier, and J.B. Brown. 2007. Progression from newly acquired impaired fasting glucose to type 2 diabetes. Diabetes Care 30(2): 228–233.

    Article  PubMed  CAS  Google Scholar 

  17. Santaguida, P.L., C. Balion, D. Hunt, K. Morrison, H. Gerstein, P. Raina, et al. 2005. Diagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucose. Evidence Report/Technology Assessment (Summary) 128: 1–11.

    Google Scholar 

  18. Guerrero-Romero, F., M. Rodríguez-Morán, R. Pérez-Fuentes, M.C. Sánchez-Guillén, M. González-Ortiz, E. Martínez-Abundis, et al. 2008. Prediabetes and its relationship with obesity in Mexican adults: The Mexican Diabetes Prevention (MexDiab) Study. Metabolic Syndrome and Related Disorders 6(1): 15–23.

    Article  PubMed  Google Scholar 

  19. Guerrero-Romero, F., and M. Rodríguez-Morán. 2002. Relationship between serum magnesium levels and C-reactive protein concentration, in non-diabetic, non-hypertensive obese subjects. International Journal of Obesity and Related Metabolic Disorders 26(4): 469–474.

    Article  PubMed  CAS  Google Scholar 

  20. Gupta, A.K., and W.D. Johnson. 2010. Prediabetes and prehypertension in disease free obese adults correlate with an exacerbated systemic proinflammatory milieu. Journal of Inflammation (Lond) 7: 36.

    Article  Google Scholar 

  21. Doi, Y., Y. Kiyohara, M. Kubo, Y. Tanizaki, K. Okubo, T. Ninomiya, et al. 2005. Relationship between C-reactive protein and glucose levels in community-dwelling subjects without diabetes: The Hisayama Study. Diabetes Care 28(5): 1211–1213.

    Article  PubMed  CAS  Google Scholar 

  22. Lin, J., M. Zhang, F. Song, J. Qin, R. Wang, P. Yao, et al. 2009. Association between C-reactive protein and pre-diabetic status in a Chinese Han clinical population. Diabetes/Metabolism Research and Reviews 25(3): 219–223.

    Article  PubMed  CAS  Google Scholar 

  23. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. 2003. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26(11): 3160–3167.

    Article  Google Scholar 

  24. Ridker, P.M. 2003. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107(3): 363–369.

    Article  PubMed  Google Scholar 

  25. Guerrero-Romero, F., L.E. Simental-Mendía, M. González-Ortiz, E. Martínez-Abundis, M.G. Ramos-Zavala, E. Martínez-Abundis, et al. 2010. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. Journal of Clinical Endocrinology and Metabolism 95(7): 3347–3351.

    Article  PubMed  CAS  Google Scholar 

  26. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. 2003. Hypertension 42(6):1206–1252.

  27. Dehghan, A., I. Kardys, M.P. de Maat, A.G. Uitterlinden, E.J. Sijbrands, A.H. Bootsma, et al. 2007. Genetic variation, C-reactive protein levels, and incidence of diabetes. Diabetes 56(3): 872–878.

    Article  PubMed  CAS  Google Scholar 

  28. Hu, F.B., J.B. Meigs, T.Y. Li, N. Rifai, and J.E. Manson. 2004. Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 53(3): 693–700.

    Article  PubMed  CAS  Google Scholar 

  29. Han, T.S., N. Sattar, K. Williams, C. Gonzalez-Villalpando, M.E. Lean, and S.M. Haffner. 2002. Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diabetes Care 25(11): 2016–2021.

    Article  PubMed  CAS  Google Scholar 

  30. Nakanishi, S., K. Yamane, N. Kamei, M. Okubo, and N. Kohno. 2003. Elevated C-reactive protein is a risk factor for the development of type diabetes in Japanese Americans. Diabetes Care 26(10): 2754–2757.

    Article  PubMed  CAS  Google Scholar 

  31. Scherer, P.E., S. Williams, M. Fogliano, G. Baldini, and H.F. Lodish. 1995. A novel serum protein similar to C1q, produced exclusively in adipocytes. Journal of Biological Chemistry 270(45): 26746–26749.

    Article  PubMed  CAS  Google Scholar 

  32. Winkler, G., S. Kiss, L. Keszthelyi, Z. Sápi, I. Ory, F. Salamon, et al. 2003. Expression of tumor necrosis factor (TNF)-alpha protein in the subcutaneous and visceral adipose tissue in correlation with adipocyte cell volume, serum TNF-alpha, soluble serum TNF-receptor-2 concentrations and C-peptide level. European Journal of Endocrinology 149(2): 129–135.

    Article  PubMed  CAS  Google Scholar 

  33. Chu, N.F., D. Spiegelman, G.S. Hotamisligil, N. Rifai, M. Stampfer, and E.B. Rimm. 2001. Plasma insulin, leptin, and soluble TNF receptors levels in relation to obesity-related atherogenic and thrombogenic cardiovascular disease risk factors among men. Atherosclerosis 157(2): 495–503.

    Article  PubMed  CAS  Google Scholar 

  34. Mathieu, P., P. Poirier, P. Pibarot, I. Lemieux, and J.P. Després. 2009. Visceral obesity: The link among inflammation, hypertension, and cardiovascular disease. Hypertension 53(4): 577–584.

    Article  PubMed  CAS  Google Scholar 

  35. Gastaldelli A, Folli F, DeFronzo RA. The product of triglycerides and glucose as index of insulin resistance. Validation in the SAM study. Journal of Clinical Endocrinology of Metabolism EPUB 28 July 2010.

Download references

Acknowledgments

This study was supported by grants from Foundation IMSS A.C. (project FIS/IMSS/PROT/542) and the National Council of Science and Technology (CONACYT) (project FOMIX-DGO-2007-C01-66735).

Author information

Authors and Affiliations

  1. Biomedical Research Unit, Mexican Social Security Institute, Predio Canoas No. 100, Col. Los Ángeles, C.P. 34067, Durango, México

    Luis E. Simental-Mendía, Brissia Lazalde, Luis Simental-Saucedo, Martha Rodríguez-Morán & Fernando Guerrero-Romero

  2. Faculty of Medicine and Nutrition, Juárez University of Durango State, Durango, Mexico

    Brissia Lazalde, Graciela Zambrano-Galván & Elizabeth Rábago-Sánchez

Authors
  1. Luis E. Simental-Mendía
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Brissia Lazalde
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Graciela Zambrano-Galván
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Luis Simental-Saucedo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Elizabeth Rábago-Sánchez
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Martha Rodríguez-Morán
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Fernando Guerrero-Romero
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Brissia Lazalde.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Simental-Mendía, L.E., Lazalde, B., Zambrano-Galván, G. et al. Relation Between C-Reactive Protein and Impaired Fasting Glucose in Obese Subjects. Inflammation 35, 1742–1746 (2012). https://doi.org/10.1007/s10753-012-9492-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10753-012-9492-z

KEY WORDS

Search

Navigation